Skip to main content
Synchron logo

Synchron

Brooklyn, NY

  • Brain-computer interfaces
  • Neurorehabilitation and assistive tech
  • Series E

Synchron develops implantable brain-computer interfaces designed to help people with motor impairment control digital devices using their thoughts. Its Stentrode BCI is delivered by catheter into a brain blood vessel, avoiding open brain surgery in the clinical-trial procedure.

Open roles
10
Posted last 30 days
5
Trials
4
Raised
$590M
Jun 2026
Series E

reccy insights

Recent highlights

Synchron’s recent milestones span financing, product integration, and organizational expansion. On Jun 29, 2026, it raised $275 million in a Series E led by General Atlantic, bringing the total of identified round amounts to $590 million. In June 2026, coverage described the company as targeting a pivotal trial for its brain-computer interface; that target should not be mistaken for confirmation that the trial has begun. Earlier, on Nov 6, 2025, Synchron announced a $200 million Series D and established an engineering hub in San Diego to support next-generation BCI development. The company also expanded its leadership team on Aug 19, 2025, appointing Andy Rasdal Chief of Staff and Mark Brister Vice President of Research and Development. Product milestones included a Aug 4, 2025 demonstration of a user controlling an iPad through the implant and a 2025 announcement of native integration plans for Apple devices. In March 2025, Synchron and NVIDIA introduced work on Chiral, a cognitive AI model using neural data and NVIDIA Holoscan. No awards are identified in the available company information.

Written by reccy's AI from company sites, press and funding records · updated Nov 2026

Open roles10

5 roles posted in the last 30 days

  1. 1Jun
  2. 1Jul
  3. 0Aug
  4. 1Sep
  5. 6Oct
  6. 1Nov
Hiring focus

Engineering and quality roles in San Diego, California.

Hiring news

No current openings listed on the official careers page.

What makes Synchron distinct

  1. 01Uses a catheter-delivered approach to place its BCI in a brain blood vessel, without open brain surgery in the clinical-trial procedure.
  2. 02Builds technology around restoring, extending, and protecting human agency.
  3. 03Aims to develop motor models for people with motor impairment and cognition models for people with cognitive decline.
  4. 04Combines implantable hardware development in San Diego with neural data and cognition research in New York City.

Technology & products2

  • Synchron Brain-Computer Interface (BCI)

    A minimally invasive brain-computer interface device that enables users to control digital devices using their thoughts.

  • Chiral™ Cognitive AI Brain Foundation Model

    A cognitive AI brain foundation model developed to enhance neurotechnology applications addressing human body limitations.

  • Stentrode implantable brain-computer interface
  • Catheter-deployed neural recording and wireless implant telemetry
  • Smartphone and tablet app for controlling digital devices through brain signals
  • Real-time neural data pipelines and closed-loop neurofeedback
  • Neural signal models for cognition

Clinical trials4

Recent updates16

  • Apr 27, 2026Award

    The 10 Most Influential New Frontiers Companies of 2026

    time.com
  • Mar 27, 2026Award

    The most innovative data science companies of 2026

    fastcompany.com
  • Dec 31, 2025Product launch

    Synchron announced plans for native integration with Apple’s BCI Human Interface Device protocol, enabling users with its implant to control iPhone, iPad, and Apple Vision Pro with their thoughts. The announcement described a planned rollout of compatible features to trial participants.

    biospace.com

In the Cortex

Funding

$590M disclosed
Latest valuation $12334 investors

Similar companies

About Synchron

Products
Synchron Brain-Computer Interface (BCI), Chiral™ Cognitive AI Brain Foundation Model
Leadership
Nicholas Opie, CTO & FounderThomas Oxley, CEO & FounderMark Brister, Vice President of Research and DevelopmentRiki Banerjee, Chief Technology Officer
Focus areas
Emerging_unicorn
Headquarters
Brooklyn, NY
Employees
101–250